Form 4: Rani Therapeutics Holdings Director Receives Stock Grant
Insider Transaction (Form 4)
Michelle Gilson, a Director of Rani Therapeutics Holdings, Inc., received 247,200 shares of common stock on August 3, 2026.
Summary
- Grant/award: acquired 247,200 Director Stock Option (Right to Buy) on August 3, 2026; holds 247,200 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Michelle Gilson — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-03 | Grant/award | Director Stock Option (Right to Buy) | 247,200 | — | — | 247,200 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-03 | Grant/award (247,200 shares) |
Keywords
insider transaction, Form 4, RANI, Rani Therapeutics Holdings, Inc., neutral, Michelle Gilson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.